Company · CIK 0000919722
Astex Pharmaceuticals, Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AAstex Pharmaceuticals, Inc0001193125-14-053526 · 230.8 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015577 · 14.4 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015576 · 13.3 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015574 · 10.7 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015573 · 44.3 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015572 · 31.2 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015571 · 10.8 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015570 · 27.2 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015569 · 27.3 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015568 · 26.9 KBSEC(opens sec.gov)
Insiders
- ABBOTT LABORATORIESInsider
- AZAB MOHAMMADChief Medical Officer
- Bearss DavidChief Scientific Officer
- Berk GregoryChief Medical Officer
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- Buckland MartinChief Business Officer
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- CASAMENTO CHARLES JDirector
- Fellner PeterDirector
Tickers
No tickers on record.
Addresses
business
4140 DUBLIN BLVD SUITE 200
DUBLIN, CA, 94568
mailing
4140 DUBLIN BLVD STE 200
DUBLIN, CA, 94568
Former names
- SUPERGEN INC2011-08-09
Same industry